APO RESEARCH · REPORT
Medical Isotopes
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
Product & engineering
Understand the product.
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Selected research
Industry Research
Medical Isotopes Industry Research Report 2026
Market perspective
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
Read the full market overview
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.
Report Scope
This report quantifies the global Medical Isotopes market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Isotopes.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Isotopes Market by Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Medical Isotopes Segment by Type
Stable Isotopes
Radioisotopes
Medical Isotopes Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Medical Isotopes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Isotopes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stable Isotopes
- Radioisotopes
Applications
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
Companies covered
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- IRE
- Nordion
- Curium Pharma
- Cambridge Isotope Laboratories
- Eckert & Ziegler Strahlen
- Polatom
- Center of Molecular Research
- China National Nuclear Corporation
- Urenco
- LANL
- Shanghai Engineering Research Center
- IDB Holland
- NHTC
- Linde
- ORNL
- SI Science
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Isotopes by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stable Isotopes
- 2.2.3 Radioisotopes
- 2.3 Medical Isotopes by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Nuclear Therapy
- 2.3.3 Equipment Radioactive Source
- 2.3.4 Diagnosis
- 2.4 Assumptions and Limitations
3 Medical Isotopes Breakdown Data by Type
- 3.1 Global Medical Isotopes Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Isotopes Forecasted Market Size by Type (2027-2032)
4 Medical Isotopes Breakdown Data by Application
- 4.1 Global Medical Isotopes Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Isotopes Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Isotopes Market Perspective (2021-2032)
- 5.2 Global Medical Isotopes Growth Trends by Region
- 5.2.1 Global Medical Isotopes Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Isotopes Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Isotopes Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Isotopes Market Dynamics
- 5.3.1 Medical Isotopes Industry Trends
- 5.3.2 Medical Isotopes Market Drivers
- 5.3.3 Medical Isotopes Market Challenges
- 5.3.4 Medical Isotopes Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Isotopes Players by Revenue
- 6.1.1 Global Top Medical Isotopes Players by Revenue (2021-2026)
- 6.1.2 Global Medical Isotopes Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Isotopes Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Isotopes Head Office and Area Served
- 6.4 Global Medical Isotopes Players, Product Type & Application
- 6.5 Global Medical Isotopes Manufacturers Established Date
- 6.6 Global Medical Isotopes Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Isotopes Market Size (2021-2032)
- 7.2 North America Medical Isotopes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Isotopes Market Size by Country (2021-2026)
- 7.4 North America Medical Isotopes Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Isotopes Market Size (2021-2032)
- 8.2 Europe Medical Isotopes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Isotopes Market Size by Country (2021-2026)
- 8.4 Europe Medical Isotopes Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Isotopes Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Isotopes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Isotopes Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Isotopes Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Isotopes Market Size (2021-2032)
- 10.2 South America Medical Isotopes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Isotopes Market Size by Country (2021-2026)
- 10.4 South America Medical Isotopes Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Isotopes Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Isotopes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Isotopes Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Isotopes Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 NRG
- 12.1.1 NRG Company Information
- 12.1.2 NRG Business Overview
- 12.1.3 NRG Revenue in Medical Isotopes Business (2021-2026)
- 12.1.4 NRG Medical Isotopes Product Portfolio
- 12.1.5 NRG Recent Developments
- 12.2 NTP Radioisotopes
- 12.2.1 NTP Radioisotopes Company Information
- 12.2.2 NTP Radioisotopes Business Overview
- 12.2.3 NTP Radioisotopes Revenue in Medical Isotopes Business (2021-2026)
- 12.2.4 NTP Radioisotopes Medical Isotopes Product Portfolio
- 12.2.5 NTP Radioisotopes Recent Developments
- 12.3 JSC Isotope
- 12.3.1 JSC Isotope Company Information
- 12.3.2 JSC Isotope Business Overview
- 12.3.3 JSC Isotope Revenue in Medical Isotopes Business (2021-2026)
- 12.3.4 JSC Isotope Medical Isotopes Product Portfolio
- 12.3.5 JSC Isotope Recent Developments
- 12.4 ANSTO
- 12.4.1 ANSTO Company Information
- 12.4.2 ANSTO Business Overview
- 12.4.3 ANSTO Revenue in Medical Isotopes Business (2021-2026)
- 12.4.4 ANSTO Medical Isotopes Product Portfolio
- 12.4.5 ANSTO Recent Developments
- 12.5 IRE
- 12.5.1 IRE Company Information
- 12.5.2 IRE Business Overview
- 12.5.3 IRE Revenue in Medical Isotopes Business (2021-2026)
- 12.5.4 IRE Medical Isotopes Product Portfolio
- 12.5.5 IRE Recent Developments
- 12.6 Nordion
- 12.6.1 Nordion Company Information
- 12.6.2 Nordion Business Overview
- 12.6.3 Nordion Revenue in Medical Isotopes Business (2021-2026)
- 12.6.4 Nordion Medical Isotopes Product Portfolio
- 12.6.5 Nordion Recent Developments
- 12.7 Curium Pharma
- 12.7.1 Curium Pharma Company Information
- 12.7.2 Curium Pharma Business Overview
- 12.7.3 Curium Pharma Revenue in Medical Isotopes Business (2021-2026)
- 12.7.4 Curium Pharma Medical Isotopes Product Portfolio
- 12.7.5 Curium Pharma Recent Developments
- 12.8 Cambridge Isotope Laboratories
- 12.8.1 Cambridge Isotope Laboratories Company Information
- 12.8.2 Cambridge Isotope Laboratories Business Overview
- 12.8.3 Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2021-2026)
- 12.8.4 Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
- 12.8.5 Cambridge Isotope Laboratories Recent Developments
- 12.9 Eckert & Ziegler Strahlen
- 12.9.1 Eckert & Ziegler Strahlen Company Information
- 12.9.2 Eckert & Ziegler Strahlen Business Overview
- 12.9.3 Eckert & Ziegler Strahlen Revenue in Medical Isotopes Business (2021-2026)
- 12.9.4 Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
- 12.9.5 Eckert & Ziegler Strahlen Recent Developments
- 12.10 Polatom
- 12.10.1 Polatom Company Information
- 12.10.2 Polatom Business Overview
- 12.10.3 Polatom Revenue in Medical Isotopes Business (2021-2026)
- 12.10.4 Polatom Medical Isotopes Product Portfolio
- 12.10.5 Polatom Recent Developments
- 12.11 Center of Molecular Research
- 12.11.1 Center of Molecular Research Company Information
- 12.11.2 Center of Molecular Research Business Overview
- 12.11.3 Center of Molecular Research Revenue in Medical Isotopes Business (2021-2026)
- 12.11.4 Center of Molecular Research Medical Isotopes Product Portfolio
- 12.11.5 Center of Molecular Research Recent Developments
- 12.12 China National Nuclear Corporation
- 12.12.1 China National Nuclear Corporation Company Information
- 12.12.2 China National Nuclear Corporation Business Overview
- 12.12.3 China National Nuclear Corporation Revenue in Medical Isotopes Business (2021-2026)
- 12.12.4 China National Nuclear Corporation Medical Isotopes Product Portfolio
- 12.12.5 China National Nuclear Corporation Recent Developments
- 12.13 Urenco
- 12.13.1 Urenco Company Information
- 12.13.2 Urenco Business Overview
- 12.13.3 Urenco Revenue in Medical Isotopes Business (2021-2026)
- 12.13.4 Urenco Medical Isotopes Product Portfolio
- 12.13.5 Urenco Recent Developments
- 12.14 LANL
- 12.14.1 LANL Company Information
- 12.14.2 LANL Business Overview
- 12.14.3 LANL Revenue in Medical Isotopes Business (2021-2026)
- 12.14.4 LANL Medical Isotopes Product Portfolio
- 12.14.5 LANL Recent Developments
- 12.15 Shanghai Engineering Research Center
- 12.15.1 Shanghai Engineering Research Center Company Information
- 12.15.2 Shanghai Engineering Research Center Business Overview
- 12.15.3 Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2021-2026)
- 12.15.4 Shanghai Engineering Research Center Medical Isotopes Product Portfolio
- 12.15.5 Shanghai Engineering Research Center Recent Developments
- 12.16 IDB Holland
- 12.16.1 IDB Holland Company Information
- 12.16.2 IDB Holland Business Overview
- 12.16.3 IDB Holland Revenue in Medical Isotopes Business (2021-2026)
- 12.16.4 IDB Holland Medical Isotopes Product Portfolio
- 12.16.5 IDB Holland Recent Developments
- 12.17 NHTC
- 12.17.1 NHTC Company Information
- 12.17.2 NHTC Business Overview
- 12.17.3 NHTC Revenue in Medical Isotopes Business (2021-2026)
- 12.17.4 NHTC Medical Isotopes Product Portfolio
- 12.17.5 NHTC Recent Developments
- 12.18 Linde
- 12.18.1 Linde Company Information
- 12.18.2 Linde Business Overview
- 12.18.3 Linde Revenue in Medical Isotopes Business (2021-2026)
- 12.18.4 Linde Medical Isotopes Product Portfolio
- 12.18.5 Linde Recent Developments
- 12.19 ORNL
- 12.19.1 ORNL Company Information
- 12.19.2 ORNL Business Overview
- 12.19.3 ORNL Revenue in Medical Isotopes Business (2021-2026)
- 12.19.4 ORNL Medical Isotopes Product Portfolio
- 12.19.5 ORNL Recent Developments
- 12.20 SI Science
- 12.20.1 SI Science Company Information
- 12.20.2 SI Science Business Overview
- 12.20.3 SI Science Revenue in Medical Isotopes Business (2021-2026)
- 12.20.4 SI Science Medical Isotopes Product Portfolio
- 12.20.5 SI Science Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst